# Salmeterol + Fluticasone

## SERETIDE 125 EVOHALER

| TAH Drug Code      | [**ESER1**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ESER1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Regular treatment of reversible obstructive airways disease (ROAD), including asthma in adult & children, where combination therapy (bronchodilator & inhaled corticosteroid) is appropriate. Seretide Accuhaler 250/Seretide Evohaler 125/Seretide Evohaler 250 Maintenance treatment of COPD including chronic bronchitis & emphysema.                                                                                                                                                                                                                                                                                                                                                               |
| Dosing             | Asthma: Adults and adolescents 12 years and older: Two inhalations of 25 mcg salmeterol and 125 mcg fluticasone propionate twice daily. or Two inhalations of 25 mcg salmeterol and 250 mcg fluticasone propionate twice daily. Children 4 years and older: 2 inhalation of 25 mcg salmeterol and 50 mcg fluticasone propionate twice daily. There are no recommended doses available in children aged under 4 years. Chronic Obstructive Pulmonary Disease (COPD): For adult patients the recommended dose is 2 inhalation 50/250 micrograms to 50/500 micrograms salmeterol/fluticasone propionate twice daily.                                                                                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | History of hypersensitivity to any of the ingredients of Seretide.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Hoarseness or dysphonia, throat irritation, headache, candidiasis of mouth & throat, palpitations, tremor, paradoxical bronchospasm, arthralgia. Gastrointestinal: Nausea (COPD, above 5% ), Oral candidiasis (asthma, 1% to 4%; COPD, 10% ) Musculoskeletal: Musculoskeletal pain (asthma, 2% to 7%; COPD, 9% ) Neurologic: Dizziness (asthma, 1% to 4%; COPD, 4% and greater ), Headache (9% to 21% ) Respiratory: Bronchitis (asthma, 2% to 8% ), Cough (asthma, 3% to 6% ), Difficulty speaking, Hoarse, Pharyngitis (asthma, 10% to 13% ), Throat irritation (7% to 9% ), Upper respiratory infection (asthma, 16% to 27%; COPD, greater than 5% ), Viral lower respiratory infection (3% to 6% ) |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

## Seretide 50 evohaler

| TAH Drug Code      | [**ESERE**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ESERE)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Regular treatment of reversible obstructive airways disease (ROAD), including asthma in adult & children, where combination therapy (bronchodilator & inhaled corticosteroid) is appropriate. Seretide Accuhaler 250/Seretide Evohaler 125/Seretide Evohaler 250 Maintenance treatment of COPD including chronic bronchitis & emphysema.                                                                                                                                                                                                                                                                                                                                                               |
| Dosing             | Asthma: Adults and adolescents 12 years and older: Two inhalations of 25 mcg salmeterol and 50 mcg fluticasone propionate twice daily. Children 4 years and older: 2 inhalation of 25 mcg salmeterol and 50 mcg fluticasone propionate twice daily. There are no recommended doses available in children aged under 4 years.                                                                                                                                                                                                                                                                                                                                                                           |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | History of hypersensitivity to any of the ingredients of Seretide.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Hoarseness or dysphonia, throat irritation, headache, candidiasis of mouth & throat, palpitations, tremor, paradoxical bronchospasm, arthralgia. Gastrointestinal: Nausea (COPD, above 5% ), Oral candidiasis (asthma, 1% to 4%; COPD, 10% ) Musculoskeletal: Musculoskeletal pain (asthma, 2% to 7%; COPD, 9% ) Neurologic: Dizziness (asthma, 1% to 4%; COPD, 4% and greater ), Headache (9% to 21% ) Respiratory: Bronchitis (asthma, 2% to 8% ), Cough (asthma, 3% to 6% ), Difficulty speaking, Hoarse, Pharyngitis (asthma, 10% to 13% ), Throat irritation (7% to 9% ), Upper respiratory infection (asthma, 16% to 27%; COPD, greater than 5% ), Viral lower respiratory infection (3% to 6% ) |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

